Physician profile
Frank Evans
NPI 1952681199
$1,221.88
in general payments reported to CMS, 2019-2025
21 companies · $17.69 in 2025
The $17.69 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $169 · 2021: $352 · 2022: $309 · 2023: $44.34 · 2024: $56.27 · 2025: $17.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $248.14 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.16 | 2022 | |
| Medtronic Vascular, INC. | $94.30 | 2019 | |
| Merck Sharp & Dohme LLC | $94.05 | 2021-2023 | Verquvo |
| Abbott Laboratories | $90.00 | 2019 | |
| Amgen INC. | $88.35 | 2020-2023 | Repatha |
| Glaxosmithkline, LLC. | $76.00 | 2019 | |
| Gilead Sciences, INC. | $74.32 | 2020 | |
| Novartis Pharmaceuticals Corporation | $67.41 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $63.88 | 2020-2022 | |
| Boston Scientific Corporation | $56.27 | 2024 | Varithena Administration Pack |
| Genentech USA, INC. | $27.85 | 2019-2020 | |
| Astellas Pharma US INC | $17.69 | 2025 | Veozah |
| Althera Pharmaceuticals LLC | $14.75 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.67 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $13.91 | 2020 | |
| Pfizer INC. | $13.75 | 2021 | |
| Medtronic, INC. | $13.60 | 2021 | |
| Novo Nordisk INC | $13.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.92 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.